GLP-1 Medications and Mental Health
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
Welcome to the first episode of Advanced Consultation with Dr. Rachel LaFleur, Dr. Julie Brownley, and Dr. Stephanie Deverich Davis. The conversation delves into the complexities of GLP-1 medications, covering their physiological impact, psychiatric application, and influence on addictive and compulsive behaviors. It also explores the challenges of prescribing GLP-1 medications and the psychological impact of highly processed foods. The conversation delves into the limited research available regarding GLP-1 medications and mental health, the multifactorial nature of treatment resistance, the interplay between inflammation and endocrine systems, the prescription and oversight of GLP-1 medications, and the sensitivity required when addressing weight and mental health issues.
Takeaways
- GLP-1 medications have a significant impact on hunger management and addictive behaviors.
- The influence of highly processed foods on hunger drive and psychological well-being is a critical area of concern. GLP-1 medications pose challenges for some individuals
- Treatment resistance is multifactorial
- Inflammation and endocrine systems are interconnected
- Prescription and oversight of GLP-1 medications require thorough evaluation
- Sensitivity is crucial when addressing weight and mental health issues
Chapters
- 00:00 Introduction to GLP-1 Medications
- 00:49 Understanding GLP-1 Medications
- 02:15 Prescribing GLP-1 Medications
- 03:13 Challenges in Prescribing GLP-1 Medications
- 04:13 Psychiatric Application of GLP-1 Medications
- 06:03 Physiological Impact of GLP-1 Medications
- 10:13 GLP-1 Medications and Addiction
- 11:21 Impact of GLP-1 Medications on Compulsive Behaviors
- 13:03 GLP-1 Medications and Hunger Management
- 19:01 The Influence of Highly Processed Foods
- 23:32 The Psychological Impact of GLP-1 Medications
- 26:28 Challenges with GLP-1 Medications
- 27:09 Multifactorial Nature of Treatment Resistance
- 31:49 Inflammation and Endocrine Interplay
- 41:01 Prescription and Oversight of GLP-1 Medications
- 48:23 Weight and Mental Health Sensitivity